AstraZeneca PLC (AZN)
174.35
-1.06
(-0.60%)
USD |
NYSE |
Nov 20, 16:00
173.88
-0.47
(-0.27%)
After-Hours: 20:00
AstraZeneca Total Return Level : 440.08 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 440.08 |
| November 19, 2026 | 442.76 |
| November 18, 2026 | 451.21 |
| November 17, 2026 | 460.07 |
| November 16, 2026 | 464.49 |
| November 13, 2026 | 465.58 |
| November 12, 2026 | 465.40 |
| November 11, 2026 | 468.18 |
| November 10, 2026 | 471.41 |
| November 09, 2026 | 478.05 |
| November 06, 2026 | 470.57 |
| November 05, 2026 | 471.63 |
| November 04, 2026 | 477.09 |
| November 03, 2026 | 464.14 |
| November 02, 2026 | 470.95 |
| October 30, 2026 | 471.13 |
| October 29, 2026 | 440.21 |
| October 28, 2026 | 427.87 |
| October 27, 2026 | 429.30 |
| October 26, 2026 | 434.30 |
| October 23, 2026 | 432.86 |
| October 22, 2026 | 435.59 |
| October 21, 2026 | 425.19 |
| October 20, 2026 | 426.12 |
| October 19, 2026 | 413.83 |
| Date | Value |
|---|---|
| October 16, 2026 | 417.52 |
| October 15, 2026 | 420.72 |
| October 14, 2026 | 408.99 |
| October 13, 2026 | 393.31 |
| October 12, 2026 | 399.65 |
| October 09, 2026 | 401.84 |
| October 08, 2026 | 400.78 |
| October 07, 2026 | 404.16 |
| October 06, 2026 | 400.35 |
| October 05, 2026 | 395.10 |
| October 02, 2026 | 396.04 |
| October 01, 2026 | 398.06 |
| September 30, 2026 | 407.57 |
| September 29, 2026 | 414.49 |
| September 28, 2026 | 419.38 |
| September 25, 2026 | 420.47 |
| September 24, 2026 | 415.37 |
| September 23, 2026 | 412.27 |
| September 22, 2026 | 424.99 |
| September 21, 2026 | 424.31 |
| September 18, 2026 | 419.21 |
| September 17, 2026 | 419.36 |
| September 16, 2026 | 411.16 |
| September 15, 2026 | 408.53 |
| September 14, 2026 | 413.40 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| GSK Plc | 183.76 |
| Johnson & Johnson | 645.40 |
| Eli Lilly & Co. | 3563.61 |
| Merck & Co., Inc. | 413.52 |
| Novo Nordisk A/S | 67.68 |